← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2014Last known activity
May 27, 2024
Timeline
2000s
- Jun 1, 2008
PegBio Co., Ltd.— Founded
Drugs by trial phase (6 distinct, 13 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT06350812Lead sponsorPhase 1/Phase 2May 27, 2024
- NCT06147544Lead sponsorPhase 1/Phase 2Jul 6, 2023
- NCT05326490Lead sponsorPhase 3May 30, 2022
- NCT05328843Lead sponsorPhase 1May 1, 2022
- NCT05102149Lead sponsorPhase 3Dec 31, 2021
- NCT05021666Lead sponsorPhase 1Jul 29, 2020
- NCT03973515Lead sponsorPhase 1Jul 15, 2019
- NCT03604419Lead sponsorPhase 2Jun 13, 2018
- NCT03520972Lead sponsorPhase 2May 7, 2018
- NCT03072407Lead sponsorPhase 1Nov 24, 2015
- NCT03059719Lead sponsorPhase 1Apr 8, 2015
- NCT03062774Lead sponsorPhase 1Nov 15, 2014
- NCT02084251Lead sponsorPhase 1Feb 1, 2014
Details
- Founded
- Suzhou, CN Jun 1, 2008
- Last known activity
- May 27, 2024